Market Place
Sourcing Support
Chiesi USA Announces 1st Analysis from the CAMEO Registry Assessing KENGREAL Use
01 Jun 2022 //
GLOBENEWSWIRE
Chiesi USA Publishes Post Hoc Analysis on Ischemic Events & KENGREAL`s role
25 Jan 2022 //
GLOBENEWSWIRE
Apotex`s Generic Metformin HCl Receives Approval in the U.S.
13 Dec 2021 //
FDA
Gland Pharma`s Generic Cangrelor Receives Approval in the U.S.
07 Dec 2021 //
FDA
MSN Labs launches generic Cangrelor, a new drug for PCI to reduce risk of MI
01 Oct 2021 //
PHARMABIZ
Chiesi USA Announces Publication of Cost-Consequence Analysis of KENGREAL
10 Aug 2021 //
BIOSPACE
Chiesi USA Announces Publication of Cost-Consequence Analysis of KENGREAL
10 Aug 2021 //
BIOSPACE
Medicines` Kengrexal (cangrelor) Approved in Europe For ACS
13 Jun 2015 //
EMA
The Medicines Company Kengreal Gets FDA Support After Previous Setbacks
13 Apr 2015 //
BIOSPACE
Antibiotics Among 7 New Drugs Backed by EMA
24 Jan 2015 //
PMLIVE
The Medicines Company Receives CHMP Positive Opinions for Three Hospital Acute Care Products: Kengrexal
23 Jan 2015 //
THE MEDICINES COMPANY
The Medicines Co.`s FDA-Rejected Cardio Drug Finds EU Success
23 Jan 2015 //
FIERCE BIOTECH
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.